JAGUAR HEALTH, INC. (JAGX)

Every figure this model derived for JAGX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 3,788,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 17,533,000 AssetsCurrent 2026-06-30
current liabilities 25,380,000 LiabilitiesCurrent 2026-06-30
equity 4,921,000 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 2026-06-30
interest expense 19,000 InterestPaidNet 2026-06-30
ocf -6,685,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 27,815,000 Revenues 2026-06-30
sbc 577,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up JAGX on one particular measure came for.

RatioValue
cash operating margin-84.18
current ratio0.7
current ratio reported0.69
deferred revenue growth0.0
dilution pct693.02
fcf margin-24.03
growth cv3.26
interest cover-1362.89
operating margin-93.1
owner earnings margin-26.11
revenue growth135.52
revenue growth per share-70.3
roic-136.69
rule of 4042.42
sbc pct revenue2.07

What to be careful about

What this model itself distrusts about JAGX's figures. Written by the derivation as it ran, not added afterwards.